Annexin Pharmaceuticals appoints Susanne Andersson as CFO
Annexin Pharmaceuticals AB (publ) has recruited Susanne Andersson as Chief Financial Officer (CFO). Susanne will take position as CFO at Annexin Pharmaceuticals during April 2023, joining the management team. She has long-standing experience as CFO with investor relations responsibility from a number of international listed companies in various industries, including Sedana Medical, Pricer, ChromoGenics and Nordic Mines. Susanne’s most recent position was an interim assignment as CFO consultant on Team Interim. “I want to thank the current CFO Henrik Palm, who will enter into